Ribavirin aerosol therapy: safety for staff.
Bortolussi
R A
RA
Gold
R
R
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000336:Aerosols; D000818:Animals; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D010564:Personnel, Hospital; D011247:Pregnancy; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000188:drug therapy; D012254:Ribavirin / Q000008:administration & dosage* / Q000009:adverse effects; D012263:Ribonucleosides / Q000008:administration & dosage*; D013723:Teratogens
D000336:Aerosols; D012263:Ribonucleosides; D013723:Teratogens; D012254:Ribavirin